Assenagon Asset Management S.A. Enanta Pharmaceuticals Inc Transaction History

Assenagon Asset Management S.A.

  • $65.1 Billion
  • Q3 2025

A detailed history of Assenagon Asset Management S.A. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 54,257 shares of ENTA stock, worth $589,231. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,257
Previous 106,380 49.0%
Holding current value
$589,231
Previous $804,000 19.28%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 07, 2025
SELL
$6.49 - $15.16 $338,278 - $790,184
-52,123 Reduced 49.0%
54,257 $649,000
Q2 2025

Jul 11, 2025
SELL
$4.26 - $7.95 $26,803 - $50,021
-6,292 Reduced 5.58%
106,380 $804,000
Q1 2025

Apr 15, 2025
SELL
$4.82 - $8.49 $386,486 - $680,762
-80,184 Reduced 41.58%
112,672 $621,000
Q4 2024

Jan 14, 2025
BUY
$5.75 - $12.99 $282,037 - $637,159
49,050 Added 34.11%
192,856 $1.11 Million
Q3 2024

Oct 23, 2024
SELL
$10.05 - $16.54 $2.84 Million - $4.68 Million
-282,755 Reduced 66.29%
143,806 $1.49 Million
Q2 2024

Jul 18, 2024
SELL
$11.43 - $17.02 $1.8 Million - $2.67 Million
-157,097 Reduced 26.92%
426,561 $5.53 Million
Q4 2023

Jan 17, 2024
SELL
$8.18 - $10.78 $392,378 - $517,095
-47,968 Reduced 7.59%
583,658 $5.49 Million
Q3 2023

Nov 06, 2023
BUY
$11.09 - $22.13 $6.02 Million - $12 Million
543,111 Added 613.58%
631,626 $7.06 Million
Q2 2023

Jul 25, 2023
SELL
$20.68 - $39.85 $617,132 - $1.19 Million
-29,842 Reduced 25.21%
88,515 $1.89 Million
Q1 2023

Apr 18, 2023
BUY
$38.82 - $54.59 $2.56 Million - $3.6 Million
65,946 Added 125.82%
118,357 $4.79 Million
Q4 2022

Jan 12, 2023
BUY
$40.77 - $53.73 $1.2 Million - $1.58 Million
29,353 Added 127.3%
52,411 $2.44 Million
Q3 2022

Oct 27, 2022
SELL
$48.29 - $71.27 $5.52 Million - $8.14 Million
-114,208 Reduced 83.2%
23,058 $1.2 Million
Q2 2022

Jul 27, 2022
BUY
$38.13 - $76.93 $79,310 - $160,014
2,080 Added 1.54%
137,266 $6.49 Million
Q1 2022

Apr 25, 2022
BUY
$56.06 - $74.11 $1.33 Million - $1.76 Million
23,703 Added 21.26%
135,186 $9.62 Million
Q4 2021

Feb 01, 2022
BUY
$60.19 - $97.37 $983,143 - $1.59 Million
16,334 Added 17.17%
111,483 $8.34 Million
Q3 2021

Oct 19, 2021
BUY
$41.02 - $58.65 $3.23 Million - $4.62 Million
78,792 Added 481.7%
95,149 $5.41 Million
Q2 2021

Jul 15, 2021
BUY
$43.76 - $53.11 $715,782 - $868,720
16,357 New
16,357 $720,000
Q4 2020

Feb 01, 2021
SELL
$41.16 - $47.47 $5.61 Million - $6.47 Million
-136,204 Closed
0 $0
Q3 2020

Oct 07, 2020
BUY
$43.36 - $53.53 $3.79 Million - $4.68 Million
87,381 Added 178.98%
136,204 $6.24 Million
Q2 2020

Jul 21, 2020
BUY
$46.37 - $57.58 $2.26 Million - $2.81 Million
48,823 New
48,823 $2.45 Million

Others Institutions Holding ENTA

# of Institutions
108
Shares Held
18.7M
Call Options Held
50K
Put Options Held
0
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $225M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email